Sudden death during the first year of life is a leading cause of infant mortality in developed countries. In neonates and infants, sudden unexplained death is classified as the sudden infant death syndrome (SIDS) when rigorous efforts to identify the cause of death including a forensic examination are unrevealing. Cardiac mechanisms including life-threatening arrhythmias are suspected to cause an undefined proportion of SIDS and recent evidence indicates that mutations in genes responsible for the congenital long QT syndrome (LQTS) are found in a significant number of cases. Molecular evidence for a link between SIDS and neonatal LOTS supports earlier observations that there is an increased risk of SIDS in infants with a QTc >440 msec based on ECG measurements in 34,000 neonates. Additional anecdotal evidence indicates that LQTS may also present as intrauterine fetal death (IUFD). These observations emphasize the need to more fully understand the prevalence and consequences of arrhythmia-promoting genetic factors in the setting of fetal, neonatal and infant mortality. The goal of this research proposal is to advance our understanding of the genetic risks influencing susceptibility to sudden death before age 1 year.
In Specific Aim 1, we will test the hypothesis that mutations in arrhythmia susceptibility genes occur in a measurable subset of SIDS victims and unexplained intrauterine fetal death in late gestation. Separately, we will determine the molecular basis for prolonged QTc interval incidentally discovered in neonates through a massive, ongoing prospective ECG screening trial conducted in Italy. The complete coding regions and splice site sequences of KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2 and coding exons of other candidate genes will be surveyed for variants in four populations, two large SIDS cohorts, a series of fetal deaths, and Italian neonatal LQTS cases identified by prospective ECG screening.
In Specific Aim 2, all mutations and rare variants in arrhythmia susceptibility genes will be analyzed for their functional and/or biochemical consequences. We hypothesize that a significant proportion of rare variants in these cases will cause dysfunction of the involved ion channel consistent with impaired myocardial repolarization. Finally, in Specific Aim 3, we will test the hypothesis that unequal expression of SCN5A alleles occurs in SIDS victims and is another potential genetic mechanism (allelic imbalance) that could contribute to the pathological impact of mutations and rare variants. Results from this study will have implications for diagnosis, treatment and prevention of LQTS, SIDS and premature fetal loss. Relevance to Public Health - Sudden unexplained death is a societal burden and vexing clinical problem affecting all age groups. SIDS remains a major reason for infant mortality in the Western world. Identifying factors, including genetic, that contribute to sudden unexpected death in infants has great importance for diagnosis and treatment of preventable causes of SIDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL083374-04
Application #
7872854
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Lathrop, David A
Project Start
2007-09-30
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
4
Fiscal Year
2010
Total Cost
$389,563
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Johnson, Christopher N; Potet, Franck; Thompson, Matthew K et al. (2018) A Mechanism of Calmodulin Modulation of the Human Cardiac Sodium Channel. Structure 26:683-694.e3
Zullo, Alberto; Frisso, Giulia; Detta, Nicola et al. (2017) Allelic Complexity in Long QT Syndrome: A Family-Case Study. Int J Mol Sci 18:
Yu, Chih-Chieh; Ko, Jum-Suk; Ai, Tomohiko et al. (2016) Arrhythmogenic calmodulin mutations impede activation of small-conductance calcium-activated potassium current. Heart Rhythm 13:1716-23
Andorin, Antoine; Behr, Elijah R; Denjoy, Isabelle et al. (2016) Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. Heart Rhythm 13:1274-82
Pipilas, Daniel C; Johnson, Christopher N; Webster, Gregory et al. (2016) Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes. Heart Rhythm 13:2012-9
Bari, Vlasta; Girardengo, Giulia; Marchi, Andrea et al. (2015) Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients. Conf Proc IEEE Eng Med Biol Soc 2015:294-7
George Jr, Alfred L (2015) Calmodulinopathy: a genetic trilogy. Heart Rhythm 12:423-4
Potet, Franck; Beckermann, Thomas M; Kunic, Jennifer D et al. (2015) Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels. Circ Arrhythm Electrophysiol 8:933-41
Makita, Naomasa; Yagihara, Nobue; Crotti, Lia et al. (2014) Novel calmodulin mutations associated with congenital arrhythmia susceptibility. Circ Cardiovasc Genet 7:466-74
Yin, Guo; Hassan, Faisal; Haroun, Ayman R et al. (2014) Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. J Am Heart Assoc 3:e000996

Showing the most recent 10 out of 35 publications